Crucial to focus on cancers unique to low, middle-income nations: US expert

Q: How long will it take to read this news story?

The story "Crucial to focus on cancers unique to low, middle-income nations: US expert" has 880 words across 27 sentences, which will take approximately 4 - 8 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Crucial to focus on cancers unique to low, middle-income nations: US expert" was covered 8 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 129 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22013705</li><li>URL: https://beamstart.com/news/crucial-to-focus-on-cancers-17233752506400</li></ul>

Business Standard Logo Business Standard 8h ago

Crucial to focus on cancers unique to low, middle-income nations: US expert - Business Standard

Quick Summary:

Krishnan, founder and president of US-based Global Initiative Against HPV and Cervical Cancer (GIAHC), was in India recently to take part in the first-ever US-India cancer dialogue held in Delhi earlier this month.

Citing data, Dr Shobha Krishnan also said that as cancer cases in India are projected to rise by nearly 13 per cent by 2025 compared to 2020, the "urgency to exchange knowledge and best practices is critical".

Low and middle-income countries are grappling with dual burden of non-communicable diseases and infection ailments, and it is crucial to "direct more attention" towards cancers prevalent or unique to such countries, a US-based cancer expert has said.